International Society for Quality of Life Research commentary on the draft European Medicines Agency reflection paper on the use of patient-reported outcome (PRO) measures in oncology studies

Kyte, D, Reeve, BB, Efficace, F et al. (9 more authors) (2016) International Society for Quality of Life Research commentary on the draft European Medicines Agency reflection paper on the use of patient-reported outcome (PRO) measures in oncology studies. Quality of Life Research, 25 (2). pp. 359-362. ISSN 0962-9343

Abstract

Metadata

Authors/Creators:
  • Kyte, D
  • Reeve, BB
  • Efficace, F
  • Haywood, K
  • Mercieca-Bebber, R
  • King, MT
  • Norquist, JM
  • Lenderking, WR
  • Snyder, C
  • Ring, L
  • Velikova, G
  • Calvert, M
Copyright, Publisher and Additional Information: © Springer International Publishing Switzerland 2015. This is an author produced version of a paper published in Quality of Life Research. The final publication is available at Springer via http://dx.doi.org/10.1007/s11136-015-1099-z. Uploaded in accordance with the publisher's self-archiving policy.
Keywords: International Society for Quality of Life Research; European Medicines Agency; Patient-reported outcomes; PROs; Health-related quality of life; HRQL; Oncology
Dates:
  • Published: February 2016
  • Accepted: 5 August 2015
Institution: The University of Leeds
Academic Units: The University of Leeds > Faculty of Medicine and Health (Leeds) > School of Medicine (Leeds)
Depositing User: Symplectic Publications
Date Deposited: 16 Oct 2015 10:08
Last Modified: 30 Oct 2016 18:09
Published Version: http://dx.doi.org/10.1007/s11136-015-1099-z
Status: Published
Publisher: Springer Verlag
Identification Number: https://doi.org/10.1007/s11136-015-1099-z
Related URLs:

Share / Export

Statistics